LOGO
LOGO

Biotech Daily Dose

DocGo Plunges On Q4 Results And Weak 2025 Revenue Outlook

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Shares of DocGo Inc. (DCGO), a provider of technology-enabled mobile health services, are down over 26% in premarket trading Friday, following the company's financial results for the fourth quarter ended Dec.31, 2024.

For the fourth quarter of 2024, total revenue declined to $120.8 million from $199.2 million in the year-ago quarter, hurt by the wind-down of migrant-related programs.

The company incurred a net loss of $7.6 million for the fourth quarter of 2024 compared to a net income of $8.0 million in the fourth quarter of 2023.

Looking ahead to the full year of 2025, the company expects revenue to be in the range of $410 million to $450 million, marking a sharp decline from the $616.6 million reported in 2024.

The company ended Dec.31, 2024, with cash of approximately $107.3 million.

DCGO closed Thursday's (Feb.27 2025) trading at $3.92, down by 3.45 percent. In premarket trading Friday, the stock is down by 26.53 percent at $2.88 on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.